Latest filing published 18 May 2023 for Atara Biotherapeutics, Inc., €36k.
Filing timeline
BuySaleInsider track record
No signal scores available.
Charlene A. Banard: trading record in brief
Charlene A. Banard is a declared insider of Atara Biotherapeutics, Inc., with filings sourced from SEC (Form 4). In total, 2 filings cover trades dated from 1 March 2023 to 16 May 2023.
Sales make up the whole of the open-market record (1 sale, €36k). Outside the open market, there are 1 share grant.
Most recently, on 18 May 2023, the filings show an open-market sale worth €36k in Atara Biotherapeutics, Inc. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Charlene A. Banard
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 19,040 shares@ US$2.037100.0% of flowCommon StockSEC:0001140361-23-025561:0
- 139,700 shares0Common StockSEC:0001140361-23-010104:0
2 of 2 declarations
